Delivery Order SPE2DB20D3103-SPE2DB23FP0L7
Award Date 7/19/23
Potential Completion Date 7/20/23
Potential Value $4.6K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award is for the delivery of Junel FE 1 mg-20 mcg tablet 28s pharmaceutical products to the Defense Logistics Agency (DLA). The $1,385.12 firm fixed-price delivery order was issued to the prime contractor, Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. This contract is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999.00, which enables efficient procurement of a wide range of pharmaceutical and...
- This federal contract award is for the delivery of pharmaceutical products, specifically the drug Junel FE 1 mg-20 mcg tablet, to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is a delivery order with a firm fixed price of $1,009.27 and has no set-aside designation, indicating open competition. The award is part of a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Junel FE 1 mg-20 mcg tablets. The $6,393.17 firm fixed-price delivery order contract has an ultimate completion date of August 25, 2022. The award is associated with a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that AmerisourceBergen's parent company, Cencora, Inc., holds with the DLA Troop Support...
- This federal contract award is for the delivery of Junel FE 1.5 mg-30 mcg tablets in quantities of 28, awarded by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract has a ceiling value of $1,081.15 and was issued as a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, valued at up to $999,999,999.00 and running through November 2026. This IDC serves as a primary...
- This federal contract award is a delivery order with a firm fixed price of $1,376.34 issued to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, awarded by the Defense Logistics Agency (DLA), has an ultimate completion date of January 15, 2025 and covers the procurement of Junel FE 1 mg-20 mcg tablets. This award is associated with a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support...
- This federal contract award is for the delivery of JUNEL FE 1.5 MG-30 MCG TABLET 28S, a pharmaceutical product, to the Defense Logistics Agency (DLA), a defense agency. The $2,696.69 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on June 17, 2025 with a completion date of June 18, 2025. The award is not associated with a set-aside program. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery...
- This federal contract award is for the delivery of Junel Fe 1 mg-20 mcg tablets in quantities of 28 per package. The $10,198.53 award was made to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) on September 15, 2021, with a completion date of September 16, 2021. The contract is a firm fixed-price delivery order, with no set-aside designation. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Junel FE 1.5 mg-30 mcg tablets. The contract, valued at $2,452.14, is a firm fixed-price delivery order that was awarded on March 25, 2022 with a completion date of March 28, 2022. AmerisourceBergen Drug Corp is a subsidiary of Cencora, Inc., which holds two significant Indefinite Delivery Contracts (IDCs) with the DLA Troop...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract, valued at $1,401.92, is for the delivery of Junel FE 1 mg-20 mcg tablets in 28-count packages. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which has a ceiling value of $999,999,999 and runs through November 2026. This IDC serves as the primary vehicle for Amerisourcebergen to...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,615.44 firm fixed price delivery order is for the provision of Junel FE 1 mg-20 mcg tablet, a prescription medication, with a performance period through December 14, 2023. This award is associated with a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB23FP0L7Delivery Order
This federal contract award is for the delivery of Junel FE 1.5 mg-30 mcg tablets, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $4,550.69 Firm Fixed Price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 held by Cencora, Inc. with the DLA Troop Support Medical, which enables the efficient procurement of a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating it was awarded through full and open competition.
Generated 2/27/25, 10:35 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.6k | 7/19/23 |